Bone marrow cells could evade immune system rejectionJanuary 29th, 2010 - 3:47 pm ICT by ANI
Washington, Jan 29 (ANI): Scientists from Iowa and Iran have used cells from mice to discover a new strategy for making embryonic stem cell transplants less likely to be rejected by a recipient’s immune system.
The strategy, involves fusing bone marrow cells to embryonic stem cells. Once fused, the hybrid cells have DNA from both the donor and recipient, raising hopes that immune rejection of embryonic stem cell therapies can be avoided without drugs.
“Our study shows that transplanted bone marrow cells fuse not only with bone marrow cells of the recipient, but with non-hematopoietic cells, suggesting that if we can understand the process of cell fusion better, we may be able to target certain organ injuries with the patient’s own bone marrow cells and repair the tissues,” said Dr. Nicholas Zavazava, a University of Iowa researcher involved in the work.
Although the study holds great promise for future embryonic stem cell therapies, the results may be even more far reaching.
The researchers used two different mouse strains, one as the donor and the other as the recipient.
When bone marrow cells were engrafted into the recipient, they tested for the presence of both donor and recipient cells and found three different types of cells- donor cells, recipient cells, and fused cells that had DNA from the donor and recipient.
They then discovered that these cells could fuse with many different types of cells in addition to embryonic stem cells, including those from the liver, kidney, heart, and gut.
Although more work is necessary to determine the exact clinical outcomes, the discovery raises the possibility that bone marrow cells could be fused to transplant organs to reduce the likelihood of rejection.
They could also be fused to failing organs to support regeneration.
“Unlike machines where the same part can be used for several different makes and models, each of us is custom built, and our immune system does the quality control,” said Dr. Gerald Weissmann, Editor-in-Chief of The FASEB Journal.
“As a result, human replacement parts, or organs, need to closely match the tissue of the recipient. This research uses bone marrow cells to fuse with a patient tissues so that nothing transplanted is rejected by our immune systems, and brings universal graft survival closer to reality,” he added.
The study was published in the latest issue of The FASEB Journal. (ANI)
- New discovery may lead to more effective stem cell therapies for leukemia - Feb 15, 2010
- Iraqi woman gets new life with bone marrow transplant in India - Sep 23, 2010
- Technique to treat the donor larynx developed - May 01, 2011
- Mums' stem cells could be key to treating genetic disease before birth - Jan 19, 2011
- Mother's bone marrow could cure diseases in unborn baby - Jan 19, 2011
- Pioneering stem cell surgery helps Brit boy grow new windpipe - Aug 06, 2010
- Stem cells from embryo sac could heal damaged hearts - May 29, 2010
- Research may pave way for new regenerative therapies - May 04, 2011
- Stem cell transplant cheap in India, but very few centres - Jan 01, 2011
- Menstrual blood stem cells can treat many ailments - May 04, 2011
- Scientists show how infection fighting cells form - Jul 10, 2012
- Novel stem cells source can form heart muscle cells, repair damage - May 29, 2010
- Scientists grow human heart in lab - Apr 04, 2011
- Stem cells may help treat aggressive multiple sclerosis - Mar 22, 2011
- Immune system can abort stem cell regeneration - Nov 21, 2011
Tags: bone marrow cells, cell fusion, clinical outcomes, different types of cells, donor cells, dr nicholas, embryonic stem cell, embryonic stem cells, hematopoietic cells, hybrid cells, immune rejection, immune system, iowa researcher, jan 29, makes and models, many different types, mouse strains, new strategy, stem cell transplants, university of iowa